<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(9)</volume><submitter>Konig JC</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Nephronophthisis (NPH) comprises a group of rare disorders accounting for up to 10% of end-stage kidney disease (ESKD) in children. Prediction of kidney prognosis poses a major challenge. We assessed differences in kidney survival, impact of variant type, and the association of clinical characteristics with declining kidney function.&lt;h4>Methods&lt;/h4>Data was obtained from 3 independent sources, namely the network for early onset cystic kidney diseases clinical registry (&lt;i>n =&lt;/i> 105), an online survey sent out to the European Reference Network for Rare Kidney Diseases (&lt;i>n =&lt;/i> 60), and a literature search (&lt;i>n =&lt;/i> 218).&lt;h4>Results&lt;/h4>A total of 383 individuals were available for analysis: 116 &lt;i>NPHP1&lt;/i>, 101 &lt;i>NPHP3&lt;/i>, 81 &lt;i>NPHP4&lt;/i> and 85 &lt;i>NPHP11/TMEM</pubmed_abstract><journal>Kidney international reports</journal><pagination>2016-2028</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9459005</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis.</pubmed_title><pmcid>PMC9459005</pmcid><pubmed_authors>Pohl M</pubmed_authors><pubmed_authors>Liebau MC</pubmed_authors><pubmed_authors>Storf H</pubmed_authors><pubmed_authors>Habbig S</pubmed_authors><pubmed_authors>Bertholet-Thomas A</pubmed_authors><pubmed_authors>Cetiner M</pubmed_authors><pubmed_authors>Dahmer-Heath M</pubmed_authors><pubmed_authors>Bockenhauer D</pubmed_authors><pubmed_authors>Antczak P</pubmed_authors><pubmed_authors>Gimpel C</pubmed_authors><pubmed_authors>Karsay R</pubmed_authors><pubmed_authors>Haffner D</pubmed_authors><pubmed_authors>Thumfart J</pubmed_authors><pubmed_authors>Konig JC</pubmed_authors><pubmed_authors>Okorn C</pubmed_authors><pubmed_authors>Ariceta G</pubmed_authors><pubmed_authors>Schlingmann KP</pubmed_authors><pubmed_authors>Nittel C</pubmed_authors><pubmed_authors>Konrad M</pubmed_authors><pubmed_authors>Bald M</pubmed_authors><pubmed_authors>Bergmann C</pubmed_authors><pubmed_authors>Konig J</pubmed_authors><pubmed_authors>Schafer F</pubmed_authors><pubmed_authors>Schanstra JP</pubmed_authors><pubmed_authors>Klopp N</pubmed_authors><pubmed_authors>Gobel J</pubmed_authors><pubmed_authors>Schermer B</pubmed_authors><pubmed_authors>Tonshoff B</pubmed_authors><pubmed_authors>Gillion V</pubmed_authors><pubmed_authors>Hoefele J</pubmed_authors><pubmed_authors>Pennekamp P</pubmed_authors><pubmed_authors>Omran H</pubmed_authors><pubmed_authors>Decramer S</pubmed_authors><pubmed_authors>Illig T</pubmed_authors><pubmed_authors>Kollmann S</pubmed_authors><pubmed_authors>Boyer O</pubmed_authors><pubmed_authors>Mastrangelo A</pubmed_authors><pubmed_authors>NEOCYST consortium</pubmed_authors><pubmed_authors>Ziegler W</pubmed_authors><pubmed_authors>Vasseur J</pubmed_authors><pubmed_authors>Telgmann AK</pubmed_authors><pubmed_authors>Schild R</pubmed_authors><pubmed_authors>Birtel J</pubmed_authors><pubmed_authors>Schlevogt B</pubmed_authors><pubmed_authors>Wohlgemuth K</pubmed_authors><pubmed_authors>Kamp-Becker I</pubmed_authors><pubmed_authors>Weber S</pubmed_authors><pubmed_authors>Lilien M</pubmed_authors><pubmed_authors>Drube J</pubmed_authors><pubmed_authors>Gerß J</pubmed_authors><pubmed_authors>Pape L</pubmed_authors><pubmed_authors>Hansen M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis.</name><description>&lt;h4>Introduction&lt;/h4>Nephronophthisis (NPH) comprises a group of rare disorders accounting for up to 10% of end-stage kidney disease (ESKD) in children. Prediction of kidney prognosis poses a major challenge. We assessed differences in kidney survival, impact of variant type, and the association of clinical characteristics with declining kidney function.&lt;h4>Methods&lt;/h4>Data was obtained from 3 independent sources, namely the network for early onset cystic kidney diseases clinical registry (&lt;i>n =&lt;/i> 105), an online survey sent out to the European Reference Network for Rare Kidney Diseases (&lt;i>n =&lt;/i> 60), and a literature search (&lt;i>n =&lt;/i> 218).&lt;h4>Results&lt;/h4>A total of 383 individuals were available for analysis: 116 &lt;i>NPHP1&lt;/i>, 101 &lt;i>NPHP3&lt;/i>, 81 &lt;i>NPHP4&lt;/i> and 85 &lt;i>NPHP11/TMEM</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-20T00:41:48.215Z</modification><creation>2025-04-20T00:41:48.215Z</creation></dates><accession>S-EPMC9459005</accession><cross_references><pubmed>36090483</pubmed><doi>10.1016/j.ekir.2022.05.035</doi></cross_references></HashMap>